Company Filing History:
Years Active: 2025
Title: Innovations of Geoffrey De Bilde in Pharmaceutical Technology
Introduction
Geoffrey De Bilde is an accomplished inventor based in Pont-à-Celles, Belgium. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of controlled-release drug delivery systems. His innovative approach has the potential to enhance the efficacy of medications and improve patient outcomes.
Latest Patents
Geoffrey De Bilde holds a patent for "Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form." This invention involves a controlled-release multilayer microparticle designed for oral administration or direct administration in the stomach. The microparticle consists of a core containing a pharmaceutically active compound, which may include pramipexole, a controlled-release intermediate coating layer, and an outer protection coating layer. The external coating layer is formulated with a mixture of hydrophilic gastro-soluble components and hydrophobic or insoluble components. This innovative design aims to provide a more effective delivery method for medications.
Career Highlights
Geoffrey De Bilde has established himself as a key figure in the pharmaceutical industry through his work at Be Pharbel Manufacturing. His expertise in drug formulation and delivery systems has led to advancements that benefit both healthcare providers and patients. His dedication to research and development has positioned him as a leader in his field.
Collaborations
Geoffrey has collaborated with notable colleagues, including Pierre Sacre and Jonathan Goole. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to the development of groundbreaking pharmaceutical solutions.
Conclusion
Geoffrey De Bilde's contributions to pharmaceutical technology, particularly through his patented innovations, demonstrate his commitment to improving drug delivery systems. His work has the potential to significantly impact the way medications are administered and absorbed, paving the way for enhanced therapeutic outcomes.